Growth Metrics

Evolent Health (EVH) Receivables - Other (2016 - 2021)

Evolent Health has reported Receivables - Other over the past 7 years, most recently at $190000.0 for Q1 2021.

  • For Q1 2021, Receivables - Other fell 89.16% year-over-year to $190000.0; the TTM value through Mar 2021 reached $190000.0, down 89.16%, while the annual FY2020 figure was $329000.0, 81.21% down from the prior year.
  • Receivables - Other for Q1 2021 was $190000.0 at Evolent Health, down from $329000.0 in the prior quarter.
  • Over five years, Receivables - Other peaked at $8.7 million in Q1 2019 and troughed at $190000.0 in Q1 2021.
  • A 5-year average of $3.5 million and a median of $3.0 million in 2018 define the central range for Receivables - Other.
  • Biggest five-year swings in Receivables - Other: skyrocketed 108.11% in 2019 and later tumbled 89.16% in 2021.
  • Year by year, Receivables - Other stood at $5.7 million in 2017, then plummeted by 63.38% to $2.1 million in 2018, then dropped by 16.7% to $1.8 million in 2019, then tumbled by 81.21% to $329000.0 in 2020, then tumbled by 42.25% to $190000.0 in 2021.
  • Business Quant data shows Receivables - Other for EVH at $190000.0 in Q1 2021, $329000.0 in Q4 2020, and $671000.0 in Q3 2020.